ARTV vs BIIB: Which Stock is Better?
Side-by-side comparison of Artiva Biotherapeutics Inc and Biogen Inc in 2026
ARTV
Artiva Biotherapeutics Inc
$10.80
BIIB
Biogen Inc
$187.06
Key Metrics Comparison
| Metric | ARTV | BIIB | Winner |
|---|---|---|---|
| Market Cap | $266.94M | $27.62B | BIIB |
| P/E Ratio | N/A | 20.11 | BIIB |
| EPS (TTM) | $N/A | $9.30 | BIIB |
| Revenue Growth | -1.0% | 0.0% | BIIB |
| Gross Margin | 0.0% | 78.7% | BIIB |
Analyze ARTV
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARTV or BIIB a better investment?
Comparing ARTV and BIIB: Artiva Biotherapeutics Inc has a market cap of $266.94M while Biogen Inc has $27.62B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARTV and BIIB?
ARTV (Artiva Biotherapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARTV or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARTV or BIIB?
BIIB has higher revenue growth at 0.0% vs -1.0% for ARTV.
Which company is more profitable: ARTV or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.7% compared to 0.0% for ARTV.
Which is the larger company: ARTV or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $27.62B compared to $266.94M for ARTV.
Should I buy ARTV or BIIB in 2026?
Both ARTV and BIIB have investment merit. ARTV trades at $10.80 while BIIB trades at $187.06. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARTV and BIIB stock?
Key differences: Market Cap ($266.94M vs $27.62B), P/E Ratio (N/A vs 20.1x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (0.0% vs 78.7%).